EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Cashmeran as a potential endocrine disrupting chemical: What does the weight-of-the-evidence indicate?

Sakshi Tayal, Marten A Schults, Paul Sterchele, Etje Hulzebos, Gregory S Ladics

Food and Chemical Toxicology · 2024

DOI: 10.1016/j.fct.2023.114351 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Food and Chemical Toxicology, 2024. Verfasst von Sakshi Tayal und 4 weiteren Autor:innen. Beteiligte Einrichtung: IFF, 6th Floor, DLF Cyber Greens, Tower C, Sector-25A, DLF City Phase 3, Gurugram, 122002, Haryana, India. Electronic address: sakshi.tayal@iff.com. Hauptthemen laut MEDLINE: Endocrine Disruptors, Indans. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cashmeran is a fragrance ingredient. Risk assessments are available but have not focused on its endocrine disruptor potential. The objective was to evaluate Cashmeran as a potential endocrine-disrupting chemical (EDC). The assessment was based on data from US EPA's CompTox Chemicals Dashboard, the Danish (Q)SAR Database, in vitro assays, and in vivo studies. ToxCast assays related to estrogen, androgen, thyroid, and steroidogenesis modalities were Inactive at non-cytotoxic concentrations. In vitro assays demonstrated no estrogenic activity in a human cervical epithelioid carcinoma HeLa cell line and indicated only weak agonist estrogenic activity in Chinese Hamster Ovary (CHO)-K1 cells. In the same test, no agonist or antagonist activity was detected for human androgen receptor (hAR) and thyroid hormone receptor β (hTHRβ) binding. The Danish QSAR database didn't indicate any ED potential. There were no adverse endocrine related effects in either a 90-day repeated gavage dosing study or a reproductive and developmental screening study. Regarding ED potential for environment, the data from two limited environmental ED related studies on Cashmeran did not raise any concern. Data from in vitro and in vivo studies were considered for environmental ED concern. Based on the weight-of-the-evidence, Cashmeran is not expected to cause endocrine effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endocrine DisruptorsIndansCricetinaeAnimalsHumansCHO CellsHeLa CellsCricetulus

Stichwörter der Autor:innen

(Q)SARCashmeranDPMIEATSEndocrineToxCastWeight of evidence

Substanzen

Endocrine Disruptors6,7-dihydro-1,1,2,3,3-pentamethyl-4-(5H)indanoneIndans

Autor:innen und Institutionen

  • IFF, 6th Floor, DLF Cyber Greens, Tower C, Sector-25A, DLF City Phase 3, Gurugram, 122002, Haryana, India. Electronic address: sakshi.tayal@iff.com.
  • IFF, Marathon 4, 1213 PJ, Hilversum, the Netherlands.
  • IFF, 650 State Highway 36, Hazlet, NJ, 07730, USA.
  • IFF, Retired from IFF, Commelinstraat 193, 1093 TP, Amsterdam, the Netherlands.
  • IFF, 200 Powder Mill Road, Wilmington, DE, 19803, USA.

Zitieren

APA

Tayal, S., Schults, M. A., Sterchele, P., Hulzebos, E., & Ladics, G. S. (2024). Cashmeran as a potential endocrine disrupting chemical: What does the weight-of-the-evidence indicate?. Food and Chemical Toxicology. https://doi.org/10.1016/j.fct.2023.114351

Vancouver

Tayal S, Schults MA, Sterchele P, Hulzebos E, Ladics GS. Cashmeran as a potential endocrine disrupting chemical: What does the weight-of-the-evidence indicate?. Food and Chemical Toxicology. 2024. doi:10.1016/j.fct.2023.114351

BibTeX
@article{Tayal2024,
  author = {Tayal, Sakshi and Schults, Marten A and Sterchele, Paul and Hulzebos, Etje and Ladics, Gregory S},
  title = {Cashmeran as a potential endocrine disrupting chemical: What does the weight-of-the-evidence indicate?},
  journal = {Food and Chemical Toxicology},
  year = {2024},
  doi = {10.1016/j.fct.2023.114351}
}
Kostenlos starten →